Details for Patent: 11,337,979
✉ Email this page to a colleague
Which drugs does patent 11,337,979 protect, and when does it expire?
Patent 11,337,979 protects LIQREV and is included in one NDA.
This patent has nine patent family members in nine countries.
Drugs Protected by US Patent 11,337,979
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cmp Dev Llc | LIQREV | sildenafil citrate | SUSPENSION;ORAL | 214952-001 | Apr 28, 2023 | DISCN | Yes | No | 11,337,979 | ⤷ Subscribe | Y | LIQREV IS INDICATED FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (WHO GROUP 1) IN ADULTS TO IMPROVE EXERCISE ABILITY AND DELAY CLINICAL WORSENING | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,337,979
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018397436 | ⤷ Subscribe | |||
| Brazil | 112020012986 | ⤷ Subscribe | |||
| Canada | 3086881 | ⤷ Subscribe | |||
| China | 111683683 | ⤷ Subscribe | |||
| European Patent Office | 3731870 | ⤷ Subscribe | |||
| Japan | 2021509114 | ⤷ Subscribe | |||
| Morocco | 50320 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
